Literature DB >> 21193959

Comparison of equine bone marrow-, umbilical cord matrix and amniotic fluid-derived progenitor cells.

Arianna Barbara Lovati1, Bruna Corradetti, Anna Lange Consiglio, Camilla Recordati, Elisa Bonacina, Davide Bizzaro, Fausto Cremonesi.   

Abstract

The aim of the study was to compare in vitro the stemness features of horse progenitor cells derived from bone marrow (BM-MSCs), amniotic fluid (AF-MSCs) and umbilical cord matrix (EUC-MSCs). It has been suggested that there may be a stem cell population within both umbilical cord matrix and amniotic fluid. However, little knowledge exists about the characteristics of these progenitor cells within these sources in the equine species. This study wanted to investigate an alternative and non-invasive stem cell source for the equine tissue engineering and to learn more about the properties of these cells for future cell banking. Bone marrow, umbilical cord and amniotic fluid samples were harvested from different horses. Cells were analyzed for proliferation, immunocytochemical, stem cell gene expression and multilineage plasticity. BM- and AF-MSCs took similar time to reach confluence and showed comparable plating efficiency. All cell lines expressed identical stem cell markers and capability to differentiate towards osteogenic lineage. Almost all cell lines differentiated into the adipogenic lineage as demonstrated by cytochemical staining, even if no adipose gene expression was detectable for AF-MSCs. AF- and EUC-MSCs showed a limited chondrogenic differentiation compared with BM-MSCs as demonstrated by histological and biochemical analyses. These findings suggest that AF-MSCs appeared to be a readily obtainable and highly proliferative cell line from an uninvasive source that may represent a good model system for stem cell biology. More studies are needed to investigate their multilineage potential. EUC-MSCs need to be further investigated regarding their particular behavior in vitro represented by spheroid formation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21193959     DOI: 10.1007/s11259-010-9457-3

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  49 in total

1.  Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes.

Authors:  Andrea Barbero; Sabine Ploegert; Michael Heberer; Ivan Martin
Journal:  Arthritis Rheum       Date:  2003-05

2.  Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment.

Authors:  R K W Smith; M Korda; G W Blunn; A E Goodship
Journal:  Equine Vet J       Date:  2003-01       Impact factor: 2.888

Review 3.  Mesenchymal stem cell aging.

Authors:  Christine Fehrer; Günter Lepperdinger
Journal:  Exp Gerontol       Date:  2005-08-25       Impact factor: 4.032

Review 4.  Regenerative medicine for tendinous and ligamentous injuries of sport horses.

Authors:  Lisa A Fortier; Roger K W Smith
Journal:  Vet Clin North Am Equine Pract       Date:  2008-04       Impact factor: 1.792

5.  Isolation and characterization of equine amniotic fluid-derived multipotent stem cells.

Authors:  Sang-Bum Park; Min-Soo Seo; Jun-Gu Kang; Joon-Seok Chae; Kyung-Sun Kang
Journal:  Cytotherapy       Date:  2010-09-22       Impact factor: 5.414

6.  Characterization and differentiation of equine umbilical cord-derived matrix cells.

Authors:  Steven M Hoynowski; Madeline M Fry; Bryn M Gardner; Matthew T Leming; Jeanell R Tucker; Linda Black; Theodore Sand; Kathy E Mitchell
Journal:  Biochem Biophys Res Commun       Date:  2007-08-13       Impact factor: 3.575

7.  Isolation of human mesenchymal stem cells from third-trimester amniotic fluid.

Authors:  Qi You; Liying Cai; Jianhua Zheng; Xiaojing Tong; Dan Zhang; Yuanlong Zhang
Journal:  Int J Gynaecol Obstet       Date:  2008-08-29       Impact factor: 3.561

8.  Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes.

Authors:  Radhika R Pochampally; Jason R Smith; Joni Ylostalo; Darwin J Prockop
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

Review 9.  Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation.

Authors:  Catherine M Kolf; Elizabeth Cho; Rocky S Tuan
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 10.  Fetal stem cells from extra-embryonic tissues: do not discard.

Authors:  Akiva J Marcus; Dale Woodbury
Journal:  J Cell Mol Med       Date:  2008-01-11       Impact factor: 5.310

View more
  21 in total

1.  Could fetal fluid and membranes be an alternative source for mesenchymal stem cells (MSCs) in the feline species? A preliminary study.

Authors:  Eleonora Iacono; Marco Cunto; Daniele Zambelli; Francesca Ricci; Pier Luigi Tazzari; Barbara Merlo
Journal:  Vet Res Commun       Date:  2012-02-12       Impact factor: 2.459

2.  Buffalo (Bubalus bubalis) term amniotic-membrane-derived cells exhibited mesenchymal stem cells characteristics in vitro.

Authors:  Kaushalya Ghosh; Rajesh Kumar; Jarnail Singh; S K Gahlawat; Dharmendra Kumar; Naresh Lalaji Selokar; S P Yadav; B R Gulati; P S Yadav
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-05-28       Impact factor: 2.416

3.  Immunophenotypic characterization and tenogenic differentiation of mesenchymal stromal cells isolated from equine umbilical cord blood.

Authors:  Niharika Mohanty; Baldev R Gulati; Rajesh Kumar; Sandeep Gera; Pawan Kumar; Rajesh K Somasundaram; Sandeep Kumar
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-01-11       Impact factor: 2.416

4.  Culture, characterization and differentiation of cells from buffalo (Bubalus bubalis) amnion.

Authors:  A Mann; R P Yadav; J Singh; D Kumar; B Singh; P S Yadav
Journal:  Cytotechnology       Date:  2012-07-21       Impact factor: 2.058

5.  Evaluation of endothelial cells differentiated from amniotic fluid-derived stem cells.

Authors:  Omar M Benavides; Jennifer J Petsche; Kenneth J Moise; Anthony Johnson; Jeffrey G Jacot
Journal:  Tissue Eng Part A       Date:  2012-03-09       Impact factor: 3.845

6.  Phenotypical and functional characteristics of mesenchymal stem cells derived from equine umbilical cord blood.

Authors:  N Mohanty; B R Gulati; R Kumar; S Gera; S Kumar; P Kumar; P S Yadav
Journal:  Cytotechnology       Date:  2014-12-09       Impact factor: 2.058

Review 7.  Amniotic fluid-derived stem cells for cardiovascular tissue engineering applications.

Authors:  Jennifer Petsche Connell; Gulden Camci-Unal; Ali Khademhosseini; Jeffrey G Jacot
Journal:  Tissue Eng Part B Rev       Date:  2013-03-14       Impact factor: 6.389

8.  Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.

Authors:  Tereza C Cardoso; Heitor F Ferrari; Andrea F Garcia; Juliana B Novais; Camila Silva-Frade; Marina C Ferrarezi; Alexandre L Andrade; Roberto Gameiro
Journal:  BMC Biotechnol       Date:  2012-05-04       Impact factor: 2.563

9.  Phenotypic and immunomodulatory properties of equine cord blood-derived mesenchymal stromal cells.

Authors:  Laurence Tessier; Dorothee Bienzle; Lynn B Williams; Thomas G Koch
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

10.  Characterization and profiling of immunomodulatory genes of equine mesenchymal stromal cells from non-invasive sources.

Authors:  Catharina De Schauwer; Karen Goossens; Sofie Piepers; Maarten K Hoogewijs; Jan L J Govaere; Katrien Smits; Evelyne Meyer; Ann Van Soom; Gerlinde R Van de Walle
Journal:  Stem Cell Res Ther       Date:  2014-01-13       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.